{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:00:35Z","timestamp":1776970835656,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim of this study was to demonstrate the effect of a novel permeation enhancer system using two existing marketed nail lacquers and the delivery of terbinafine through human nail samples in vitro.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Initially a modified Franz cell was used, where sections of human nail serve as the barrier through which drug penetrates into an agar-filled chamber infected with dermatophytes. A second study was performed using a novel infected nail model where dermatophytes are incubated with and grow into human nail and ATP levels are used as biological marker for antimicrobial activity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The novel permeation enhancing system increased the permeation of both existing drugs formulated in nail lacquers and terbinafine through human nail sections mounted in a modified Franz cell. Furthermore the ATP assay confirmed that the system also enhanced the permeation of terbinafine through infected cadaver nail resulting in a decrease in ATP levels equivalent to those of uninfected negative control samples.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study has clearly demonstrated that the use of a novel permeation enhancing system, which fundamentally alters the chemical structure of the nail, not only enhances the efficacy of the existing topical formulations but also enables the delivery and efficacy of terbinafine when applied ungually. Such a topically applied system has the possibility of overcoming the systemic side effects when terbinafine is delivered orally.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1211\/jpp.62.06.0009","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T20:56:40Z","timestamp":1441313800000},"page":"730-737","source":"Crossref","is-referenced-by-count":34,"title":["Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents"],"prefix":"10.1093","volume":"62","author":[{"given":"M J","family":"Traynor","sequence":"first","affiliation":[{"name":"School of Pharmacy, University of Hertfordshire , Hatfield,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R B","family":"Turner","sequence":"additional","affiliation":[{"name":"MedPharm Ltd , Guildford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R G","family":"Evans","sequence":"additional","affiliation":[{"name":"MedPharm Ltd , Guildford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R H","family":"Khengar","sequence":"additional","affiliation":[{"name":"Pharmaceutical Science Research Division, King's, College London , London,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Jones","sequence":"additional","affiliation":[{"name":"Pharmaceutical Science Research Division, King's, College London , London,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M B","family":"Brown","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Hertfordshire , Hatfield,","place":["UK"]},{"name":"MedPharm Ltd , Guildford,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,6,1]]},"reference":[{"key":"2024103013094880100_cit1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2133.1993.tb03510.x","article-title":"The epidemiology of onychomycosis in Britain","volume":"129","author":"Williams","year":"1993","journal-title":"Br J Dermatol"},{"issue":"5 Pt 2","key":"2024103013094880100_cit2","first-page":"395","article-title":"Prevalence, morbidity, and cost of dermatological diseases","volume":"73","year":"1979","journal-title":"J Invest Dermatol"},{"key":"2024103013094880100_cit3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CMR.11.3.415","article-title":"Onychomycosis: pathogenesis, diagnosis, and management","volume":"11","author":"Elewski","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 1","key":"2024103013094880100_cit4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1439-0507.1996.tb00517.x","article-title":"[Increasing frequency of onychomycoses \u2013 is there a change in the spectrum of infectious agents?]","volume":"39","author":"Ginter","year":"1996","journal-title":"Mycoses"},{"key":"2024103013094880100_cit5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/bmj.304.6835.1151","article-title":"Short term treatment of dermatophyte onychomycosis with terbinafine","volume":"304","author":"Goodfield","year":"1992","journal-title":"BMJ"},{"key":"2024103013094880100_cit6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1365-2133.1995.tb02741.x","article-title":"The prevalence of onychomycosis in Finland","volume":"133","author":"Heikkila","year":"1995","journal-title":"Br J Dermatol"},{"issue":"Suppl 39","key":"2024103013094880100_cit7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1992.tb00005.x","article-title":"Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey","volume":"126","author":"Roberts","year":"1992","journal-title":"Br J Dermatol"},{"key":"2024103013094880100_cit8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2133.1995.tb00722.x","article-title":"Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study","volume":"132","author":"Sais","year":"1995","journal-title":"Br J Dermatol"},{"key":"2024103013094880100_cit9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(02)00321-6","article-title":"Nail morphology studies as assessments for onychomycosis treatment modalities","volume":"245","author":"Repka","year":"2002","journal-title":"Int J Pharm"},{"key":"2024103013094880100_cit10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1211\/0022357991772448","article-title":"Drug permeation through the three layers of the human nail plate","volume":"51","author":"Kobayashi","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"2024103013094880100_cit11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archderm.1959.01560150001001","article-title":"The treatment of dermatomycoses with orally administered griseofulvin","volume":"79","author":"Blank","year":"1959","journal-title":"AMA Arch Dermatol"},{"issue":"Suppl.","key":"2024103013094880100_cit12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2133.1992.tb00008.x","article-title":"A randomized treatment duration-finding study of terbinafine in onychomycosis","volume":"126","author":"Van der Schroeff","year":"1992","journal-title":"Br J Dermatol"},{"key":"2024103013094880100_cit13","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00000441-200305000-00008","article-title":"Terbinafine-associated hepatotoxicity","volume":"325","author":"Ajit","year":"2003","journal-title":"Am J Med Sci"},{"key":"2024103013094880100_cit14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2133.1989.tb08217.x","article-title":"Treatment of dermatophyte infection of the finger- and toe-nails with terbinafine (SF 86-327, Lamisil), an orally active fungicidal agent","volume":"121","author":"Goodfield","year":"1989","journal-title":"Br J Dermatol"},{"key":"2024103013094880100_cit15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00042737-200109000-00021","article-title":"Terbinafine-induced hepatic dysfunction","volume":"13","author":"Chambers","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2024103013094880100_cit16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7547\/87507315-90-10-491","article-title":"The dermatopharmacologic profile of ciclopirox 8% nail lacquer","volume":"90","author":"Bohn","year":"2000","journal-title":"J Am Podiatr Med Assoc"},{"issue":"4 Suppl.","key":"2024103013094880100_cit17","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1067\/mjd.2000.109072","article-title":"Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis","volume":"43","author":"Bohn","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4 Suppl.","key":"2024103013094880100_cit18","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1067\/mjd.2000.109068","article-title":"Ciclopirox nail lacquer solution 8% in the 21st century","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4 Suppl.","key":"2024103013094880100_cit19","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1067\/mjd.2000.109071","article-title":"Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. [see comment]","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"4 Suppl.","key":"2024103013094880100_cit20","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1067\/mjd.2000.109069","article-title":"Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States","volume":"43","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"2024103013094880100_cit21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.0933-7407.2003.00932.x","article-title":"Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis","volume":"46","author":"Seebacher","year":"2003","journal-title":"Mycoses"},{"key":"2024103013094880100_cit22","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jps.20773","article-title":"Variability in human skin permeability in vitro: comparing penetrants with different physicochemical properties","volume":"96","author":"Akomeah","year":"2007","journal-title":"J Pharm Sci"},{"key":"2024103013094880100_cit23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0928-0987(01)00167-1","article-title":"Novel mechanisms and devices to enable successful transdermal drug delivery","volume":"14","author":"Barry","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"2024103013094880100_cit24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp Dermatol"},{"key":"2024103013094880100_cit25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/10717540500455975","article-title":"Dermal and transdermal drug delivery systems: current and future prospects","volume":"13","author":"Brown","year":"2006","journal-title":"Drug Deliv"},{"key":"2024103013094880100_cit26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-59745-210-6_5","article-title":"Transdermal drug delivery systems: skin perturbation devices","volume":"437","author":"Brown","year":"2008","journal-title":"Methods Mol Biol"},{"key":"2024103013094880100_cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00731-1","article-title":"Skin, the final frontier","volume":"224","author":"Hadgraft","year":"2001","journal-title":"Int J Pharm"},{"key":"2024103013094880100_cit28","first-page":"8","article-title":"Human in vivo studies of dermal penetration, their relation to in vitro prediction","volume-title":"Perspectives in Percutaneous Penetration","author":"Kezic","year":"2004"},{"key":"2024103013094880100_cit29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-642-74054-1_12","article-title":"The properties of skin as a diffusion barrier and route for absorption","volume-title":"Pharmacology of the Skin I","author":"Scott","year":"1989"},{"key":"2024103013094880100_cit30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0167-4838(99)00129-6","article-title":"Hydration of human nails investigated by NIR-FT-Raman spectroscopy","volume":"1433","author":"Wessel","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"2024103013094880100_cit31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1081\/DDC-43935","article-title":"In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer","volume":"31","author":"Monti","year":"2005","journal-title":"Drug Dev Ind Pharm"},{"key":"2024103013094880100_cit32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jps.10058","article-title":"Investigation of nail permeation enhancement by chemical modification using water as a probe","volume":"91","author":"Malhotra","year":"2002","journal-title":"J Pharm Sci"},{"key":"2024103013094880100_cit33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1517\/17425240802497218","article-title":"Enhancing the nail permeability of topically applied drugs","volume":"5","author":"Murdan","year":"2008","journal-title":"Exp Opin Drug Deliv"},{"key":"2024103013094880100_cit34","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s11095-007-9368-3","article-title":"Nail swelling as a pre-formulation screen for the selection and optimisation of ungual penetration enhancers","volume":"24","author":"Khengar","year":"2007","journal-title":"Pharm Res"},{"key":"2024103013094880100_cit35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2008.11.009","article-title":"Overcoming the nail barrier: a systematic investigation of ungual chemical penetration enhancement","volume":"370","author":"Brown","year":"2009","journal-title":"Int J Pharm"},{"key":"2024103013094880100_cit36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0738-081X(01)00201-2","article-title":"Hair care products: waving, straightening, conditioning, and coloring","volume":"19","author":"Bolduc","year":"2001","journal-title":"Clin Dermatol"},{"key":"2024103013094880100_cit37","first-page":"496","article-title":"Permanent waving and straightening of hair","volume":"39","author":"Wickett","year":"1987","journal-title":"Cutis"},{"key":"2024103013094880100_cit38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00019053-199609040-00004","article-title":"Clinical and economic factors in the treatment of onychomycosis","volume":"9","author":"Einarson","year":"1996","journal-title":"Pharmacoeconomics"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/6\/730\/60233170\/jpp.62.06.0009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/6\/730\/60233170\/jpp.62.06.0009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:39:29Z","timestamp":1730313569000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/62\/6\/730\/6135598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6,1]]},"published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.62.06.0009","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,6]]},"published":{"date-parts":[[2010,6,1]]}}}